Information Needed for a Biocatalysis Project Quote

Creative Enzymes Resource Guide

Information Needed for a Biocatalysis Project Quote

A practical RFQ preparation guide for enzyme screening, route feasibility, recombinant production, assay development, reaction optimization, and bioprocess support.

A useful biocatalysis quote depends on more than a project title. The same request, such as "screen enzymes for a chiral alcohol" or "optimize an enzyme reaction," can describe very different scopes depending on the substrate, available sample amount, target product, analytical readiness, scale, timeline, success criteria, and previous data. Clear project information helps Creative Enzymes recommend the right technical path and avoid quoting unnecessary work.

The goal of an RFQ package is not to have every answer before contacting Creative Enzymes. It is to provide enough context to define the decision that the project must support. A feasibility study, commercial enzyme screen, custom recombinant expression project, enzyme engineering program, immobilization evaluation, or process development package all require different information and deliverables. The more precisely the decision is defined, the more accurately the project can be scoped.

Submit a Project Inquiry Explore Biocatalysis Services

A strong RFQ package should let the technical team understand the molecule, the reaction, the data gap, the desired decision, and the practical constraints. It does not need to be perfect, but it should be specific.

Why Quote Information Matters in Biocatalysis

Biocatalysis projects vary widely in complexity. A request to screen an off-the-shelf enzyme panel may require a target substrate, assay method, and a few grams or milligrams of material. A custom route feasibility project may require multiple enzyme families, cofactor regeneration, chiral analysis, substrate solubility testing, and confirmatory LC-MS or NMR. A process development project may require substrate loading studies, pH control, enzyme loading optimization, downstream recovery, impurity tracking, and scale-up planning.

When key information is missing, the quote must either make conservative assumptions or split the work into a preliminary assessment. That can be appropriate, especially for confidential or early-stage projects, but the scope will be more accurate if the inquiry explains what is known and what is still uncertain. It is also useful to state whether the project is exploratory, time-sensitive, budget-limited, or intended to support a downstream manufacturing decision.

Information Category	Why Creative Enzymes Needs It	How It Affects the Quote
Target reaction and product	Defines enzyme families, assay design, route options, and success criteria.	Determines whether the project is screening, route evaluation, optimization, or custom development.
Substrate and sample availability	Controls feasible assay scale, replicate count, confirmation testing, and follow-up experiments.	Influences material requirements, number of conditions, and whether microscale or preparative work is possible.
Analytical readiness	Shows whether conversion, product identity, selectivity, and impurities can be measured reliably.	May add method development, product standard preparation, chiral method work, or LC-MS confirmation.
Scale and timeline	Clarifies whether the project supports discovery, route selection, gram demonstration, or process development.	Shapes the number of phases, deliverables, reporting depth, and urgency assumptions.
Previous data	Prevents duplicated work and identifies known failure modes.	Can reduce screening scope or redirect the quote toward troubleshooting, engineering, or optimization.
Confidentiality and deliverables	Defines data-sharing limits, documentation requirements, and reporting format.	May influence NDA timing, project communication, report structure, and material handling.

Target Reaction and Product Information

The most important part of a biocatalysis RFQ is the reaction definition. Include the target product structure, starting material structure, desired transformation, and any stereochemical or regioselective requirements. If the final target is confidential, a representative structure, masked structure, functional group description, or reaction class can sometimes support preliminary scoping, but exact chemistry usually improves the technical recommendation.

For chiral molecules, specify the desired absolute configuration, enantiomeric or diastereomeric excess requirement, and whether reference standards are available. For selective oxidation, hydrolysis, amination, reduction, nitrile transformation, esterification, phosphorylation, glycosylation, or cascade reactions, describe which bond should form or break and which functional groups must remain unchanged. If the product is an intermediate in a larger route, mention the downstream step because impurity tolerance and salt form may matter.

Reaction Detail	Useful Information to Provide	Why It Matters
Reaction type	Reduction, oxidation, transamination, reductive amination, hydrolysis, nitrile conversion, acylation, cascade, or other transformation.	Guides enzyme family selection and identifies cofactors, donors, acceptors, or partner enzymes.
Starting material	Structure, salt form, stereochemistry, purity, solubility, stability, and available amount.	Determines feasible screen design, substrate-loading range, and need for solubility or stability checks.
Target product	Structure, desired configuration, purity target, product standard availability, and final use as intermediate or product.	Defines analytical confirmation, chiral method needs, and success criteria.
Selectivity requirement	ee, de, regioselectivity, chemoselectivity, functional-group tolerance, or allowed side products.	Helps rank enzyme hits by process value rather than conversion alone.
Route position	Whether the enzymatic step is early, late, final, or used to make a building block.	Influences impurity tolerance, workup expectations, and whether mild conditions or metal avoidance is important.
Alternative routes	Known chemical route, current yield, selectivity issue, cost concern, or sustainability motivation.	Helps define what the biocatalytic option must improve to be valuable.

Overview of information needed for a biocatalysis project quote including target reaction, substrate, product, analytics, scale, timeline, success criteria, and prior data.

Substrate, Product, and Sample Logistics

Material availability affects the practical design of the project. A broad commercial enzyme screen can often be performed at small scale, but confirmatory analysis, time-course work, substrate-loading studies, product isolation, and chiral method validation require more material. If only a few milligrams of substrate are available, the quote may need to prioritize a staged workflow: first establish an assay and small screen, then expand only after a hit appears.

Substrate quality should also be described. Enzymes can be sensitive to salt form, solvent residue, water content, stereoisomer composition, stabilizers, protecting groups, and impurities. Product standards are highly useful because they accelerate method development and reduce ambiguity in hit confirmation. If no product standard is available, the project may need LC-MS, NMR, derivatization, or preparative confirmation work.

Material Detail	Best Information to Share	Quote Impact
Substrate amount	Available mass or volume now, expected resupply date, and whether material is precious or scalable.	Defines screen size, replicate count, confirmation scale, and whether staged testing is needed.
Substrate purity and form	Purity, salt form, hydrate/solvate state, stereochemistry, residual solvent, and known impurities.	Helps avoid false negatives caused by impurities, wrong form, or poor solubility.
Solubility and stability	Known solubility in buffer or cosolvent, pH sensitivity, degradation, volatility, or precipitation behavior.	May add solubility screening, fed-batch strategy, biphasic testing, or stability controls.
Product standard	Availability of authentic product, chiral standards, isomer standards, or reference chromatograms.	Improves product confirmation and may reduce analytical development time.
Sample handling constraints	Toxicity, controlled substance status, temperature sensitivity, light sensitivity, shipping restrictions, or special storage.	Influences logistics, safety review, storage, project start timing, and handling procedures.
Confidential structures	Whether full structures can be shared under NDA or only masked structures are available for preliminary scoping.	May split the project into NDA review, preliminary scoping, and final technical quote.

Biocatalytic Route Objective and Success Criteria

Different project objectives require different quote structures. A feasibility project asks whether a biocatalytic route is possible. A screening project asks which enzymes or enzyme families are active. An optimization project asks how to improve a known hit. An engineering project asks how to improve activity, selectivity, stability, expression, solvent tolerance, or substrate loading. A process development project asks whether the route can be scaled and integrated with downstream recovery.

Success criteria should be stated as clearly as possible. Examples include a minimum conversion, desired ee or de, target product titer, maximum enzyme loading, acceptable reaction time, target substrate loading, required isolated amount, impurity limit, or decision threshold for advancing to the next phase. If the criteria are unknown, say so. Creative Enzymes can propose practical milestone criteria based on the project stage.

Project Objective	Typical Deliverable	Useful Success Criteria
Route feasibility evaluation	Technical assessment of enzyme route options, risks, assay needs, and recommended next experiment.	Clear go/no-go recommendation and prioritized enzyme families or route strategies.
Commercial enzyme screening	Panel screen under defined conditions with hit ranking and confirmation of product formation.	Minimum conversion, selectivity, product identity evidence, and reproducibility of top hits.
Substrate specificity screening	Comparison of enzyme activity across substrate analogs, variants, or related molecules.	Relative activity, substrate scope map, and identification of promising structural features.
Reaction condition optimization	pH, temperature, solvent, cofactor, donor, enzyme loading, substrate loading, and time-course optimization.	Improved conversion, yield, selectivity, loading, productivity, or impurity profile.
Enzyme engineering	Variant design, library construction or screening, expression, activity testing, and lead variant comparison.	Defined improvement in activity, selectivity, stability, expression, or process tolerance.
Bioprocess development	Scale-relevant studies on substrate loading, catalyst format, cofactor regeneration, workup, and reproducibility.	Process-ready data package supporting gram, kilogram, or transfer-stage decisions.

Analytical Method and Data Readiness

Analytical readiness is often the difference between a fast quote and a phased quote. If a validated or working analytical method already exists, share the method conditions, chromatograms, response factors, standards, and known limitations. If no method exists, the quote may need to include assay development before screening. Screening without reliable analytics can generate false positives, false negatives, or data that cannot support the next decision.

For many biocatalysis projects, direct product analysis is needed. HPLC, UPLC, GC, LC-MS, GC-MS, NMR, chiral HPLC, chiral GC, SFC, or derivatized methods may be appropriate depending on the substrate and product. Cofactor absorbance, colorimetric assays, fluorescent assays, and coupled readouts can be useful for high-throughput screening, but important hits usually require product-specific confirmation.

Analytical Information	Why It Helps	When Extra Method Work May Be Needed
Substrate and product method	Allows conversion and yield to be measured directly.	Peaks overlap, response factors are unknown, or no product standard is available.
Chiral method	Confirms ee, de, stereochemical direction, and whether the desired enantiomer is formed.	Target is chiral, standards are unavailable, or product racemization is possible.
Impurity tracking	Shows whether side products, donor products, cofactor products, or degradation products affect route value.	High conversion is observed but mass balance or product purity is poor.
Assay controls	Distinguishes true enzyme conversion from background reaction or assay interference.	Optical, coupled, crude lysate, whole-cell, or cofactor-based readouts are used.
Product identity evidence	Confirms that the intended molecule is formed rather than an isomer or side product.	Project relies on LC area only, product standard is missing, or unknown peaks appear.
Raw data examples	Lets the technical team understand current method quality and limitations.	Quote must include troubleshooting, re-analysis, or method transfer planning.

RFQ preparation map for a biocatalysis project showing project objective, materials, analytics, scale, timeline, prior data, confidentiality, and deliverables.

Scale, Timeline, Budget Context, and Deliverables

Scale information helps align the quote with the real purpose of the project. A milligram-scale screen, gram-scale demonstration, kilogram-oriented route study, and long-term enzyme supply project require different planning. Even if the final commercial scale is far away, it is useful to state the desired next milestone: hit identification, proof of product formation, 100 mg isolated product, gram-scale demonstration, process metric comparison, or route transfer package.

Timeline and deliverables also matter. Some projects need a quick feasibility answer. Others require a detailed technical report with methods, data tables, chromatograms, and recommendations. Some need isolated product, enzyme material, recombinant strain information, sequence data, or a supply proposal. If there is a target budget range or phased approval process, sharing it can help Creative Enzymes propose a realistic scope.

Planning Detail	Examples to Provide	Scoping Effect
Current project stage	Early discovery, route feasibility, lead enzyme optimization, process development, or supply qualification.	Determines technical depth, risk tolerance, and reporting level.
Desired scale	Microscale screen, analytical confirmation, milligram product, gram product, kilogram-oriented study, or bulk enzyme supply.	Influences material needs, reaction setup, workup, and deliverables.
Timeline	Preferred start date, decision deadline, sample arrival date, and urgency of the result.	Shapes project phasing, resource allocation, and whether a rapid preliminary study is recommended.
Report expectations	Summary memo, full technical report, raw data package, chromatograms, presentation, or transfer protocol.	Defines documentation effort and communication plan.
Material deliverables	Isolated product, enzyme sample, recombinant protein, immobilized catalyst, screened panel data, or optimized protocol.	May add purification, formulation, stability, shipping, or quality-control tasks.
Budget or phase constraints	Exploratory budget, staged approval, fixed pilot scope, or need for alternative quote options.	Helps build a phased proposal with optional follow-up work instead of an overbroad scope.

Previous Data, Failed Attempts, and Reference Routes

Previous data are extremely valuable, including failed experiments. If an enzyme panel gave no hits, share the panel type, conditions, cofactors, substrate loading, assay method, and controls. If a reaction produced low conversion, share time-course data, enzyme loading, pH, temperature, solvent, donor or cofactor system, and product identity evidence. If the issue is selectivity, share chiral method data and any known stereochemical assignment.

Reference routes also help. A chemical benchmark can define what the enzyme route must improve: ee, yield, impurity profile, sustainability, cost, safety, metal removal, or route length. Literature examples can suggest enzyme families or conditions, but they should be interpreted carefully because small substrate changes can alter activity and selectivity.

Helpful Previous Data

Enzyme names, sources, sequence IDs, activity units, lots, expression host, or catalyst format already tested.
Reaction conditions including pH, buffer, temperature, solvent, substrate loading, enzyme loading, cofactor, donor, and time.
Analytical results such as conversion, ee/de, product identity, raw chromatograms, LC-MS traces, or NMR data.
Observed failure modes including no conversion, low activity, substrate precipitation, product instability, or assay disagreement.

Helpful Reference Context

Current chemical route, yield, selectivity, impurity issue, safety concern, or sustainability objective.
Relevant literature examples, patents, commercial enzyme references, or internal route notes.
Known constraints on solvent, pH, temperature, metals, animal-derived materials, host organisms, or product salt form.
Downstream use of the product and which impurities or residual reagents matter most.

How Creative Enzymes Scopes a Biocatalysis Quote

Creative Enzymes scopes a project by matching the technical objective to the smallest credible work plan that can answer the decision question. If the key uncertainty is whether any enzyme can perform the target chemistry, a screening or route feasibility phase may be recommended. If a known enzyme is active but weak, condition optimization or enzyme engineering may be more appropriate. If the reaction appears to work but the data are inconsistent, assay validation or troubleshooting may come first.

Many projects are best quoted in phases. Phase 1 may confirm analytics and feasibility. Phase 2 may expand screening or optimize hits. Phase 3 may develop process conditions, scale-up, immobilization, engineering, or enzyme supply. A phased quote reduces risk because the next step is informed by data rather than assumptions.

If the Main Uncertainty Is...	Likely First Scope	Possible Follow-Up
Whether biocatalysis is suitable for the route	Route feasibility review and recommended enzyme-family strategy.	Focused enzyme screen or candidate mining.
Which commercial enzyme is active	Commercial enzyme library screening with product confirmation.	Secondary screen, condition optimization, or larger confirmation run.
Whether a sequence candidate can be produced	Custom recombinant expression, purification, and activity confirmation.	Expression optimization, homolog comparison, or enzyme engineering.
Why a reaction is inconsistent or inactive	Troubleshooting of enzyme quality, assay method, cofactor system, substrate behavior, and conditions.	Redesigned assay, condition optimization, or alternate enzyme family screen.
How to improve a known hit	Reaction condition optimization or small focused variant/homolog comparison.	Enzyme engineering, immobilization, or process development.
Whether the process can scale	Substrate loading, time course, catalyst loading, cofactor regeneration, workup, and reproducibility study.	Gram demonstration, bioprocess development, catalyst supply, or technology transfer package.

Request Details for a Biocatalysis Project Quote

The checklist below can be used as a practical inquiry template. Include what you have; it is acceptable to mark unknown items as unknown.

Project title, target reaction, substrate structure, product structure, desired stereochemistry, and route objective.
Substrate amount available, product standard availability, purity, salt form, solubility, stability, and shipping or storage constraints.
Preferred enzyme family or open route options, such as KRED, TA, IRED, RedAm, lipase, esterase, nitrilase, oxidase, monooxygenase, or cascade.
Analytical method, raw data, standards, chiral method, product identity evidence, and known assay limitations.

Success criteria: conversion, yield, ee/de, substrate loading, reaction time, product amount, impurity limit, or go/no-go decision.
Previous experiments, failed attempts, reference route, literature examples, commercial enzyme data, or internal constraints.
Desired scale, timeline, budget context, deliverables, report format, sample return needs, and communication preference.
NDA status, confidentiality restrictions, IP considerations, material safety information, and purchasing or vendor onboarding requirements.